The Pennant Group's (PNTG) Hold (C) Rating Reaffirmed at Weiss Ratings

Key Points

• The Pennant Group's stock rating has been reaffirmed as "hold (c)" by Weiss Ratings, indicating a neutral outlook for investors.
• Wells Fargo & Company and Truist Financial both reduced their target prices for the stock, reflecting a cautious sentiment among analysts.
• A consensus price target of $34.40 suggests an average optimistic outlook, amidst mixed ratings from various research analysts.

The Pennant Group (NASDAQ:PNTG - Get Free Report)'s stock had its "hold (c)" rating reaffirmed by Weiss Ratings in a research report issued to clients and investors on Tuesday,Weiss Ratings reports.

Several other research analysts also recently weighed in on the company. Wells Fargo & Company reduced their target price on The Pennant Group from $31.00 to $29.00 and set an "equal weight" rating for the company in a research note on Thursday, August 14th. Truist Financial reduced their target price on The Pennant Group from $32.00 to $28.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Stephens reaffirmed an "overweight" rating and set a $40.00 target price on shares of The Pennant Group in a research note on Thursday, October 9th. Finally, Wall Street Zen downgraded The Pennant Group from a "buy" rating to a "hold" rating in a research note on Friday, September 26th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $34.40.

The Pennant Group Price Performance

Shares of PNTG stock traded down $0.14 during trading hours on Tuesday, hitting $23.86. 31,838 shares of the company's stock were exchanged, compared to its average volume of 256,297. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.11. The firm has a market cap of $824.43 million, a P/E ratio of 30.67, a P/E/G ratio of 2.00 and a beta of 1.35. The firm has a 50 day moving average of $24.80 and a two-hundred day moving average of $25.90. The Pennant Group has a fifty-two week low of $21.18 and a fifty-two week high of $36.20.

Institutional Trading of The Pennant Group

Several large investors have recently added to or reduced their stakes in PNTG. GAMMA Investing LLC grew its holdings in The Pennant Group by 7,124.5% in the 1st quarter. GAMMA Investing LLC now owns 7,947 shares of the company's stock valued at $200,000 after buying an additional 7,837 shares in the last quarter. Rhumbline Advisers grew its holdings in The Pennant Group by 8.6% in the 1st quarter. Rhumbline Advisers now owns 47,423 shares of the company's stock valued at $1,193,000 after buying an additional 3,750 shares in the last quarter. SG Americas Securities LLC grew its holdings in The Pennant Group by 56.9% in the 1st quarter. SG Americas Securities LLC now owns 23,413 shares of the company's stock valued at $589,000 after buying an additional 8,490 shares in the last quarter. Balance Wealth LLC purchased a new stake in The Pennant Group in the 1st quarter valued at $317,000. Finally, Rice Hall James & Associates LLC grew its holdings in The Pennant Group by 43.8% in the 1st quarter. Rice Hall James & Associates LLC now owns 240,649 shares of the company's stock valued at $6,052,000 after buying an additional 73,300 shares in the last quarter. 85.88% of the stock is currently owned by hedge funds and other institutional investors.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.